| Line Item | 2022-11-30 | Y/Y |
|---|---|---|
| R&D Expense | $1.1M | — |
| SG&A Expense | $1.3M | -15.2% |
| Income Tax | $0 | — |
| Net Income | -$24.3M | -12.0% |
| EPS (Basic) | -$0.17 | -13.3% |
| EPS (Diluted) | -$0.17 | -13.3% |
| Line Item | 2022-11-30 | Y/Y |
|---|---|---|
| Accounts Receivable | $17K | -10.5% |
| Current Assets | $2.9M | -56.0% |
| Total Assets | $146.0M | -12.7% |
| Current Liabilities | $534K | -48.2% |
| Total Liabilities | $567K | -55.2% |
| Stockholders' Equity | $145.4M | -12.4% |
| Line Item | 2022-11-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$3.9M | +23.1% |
| Investing Cash Flow | $142K | +219.3% |
| Financing Cash Flow | $54K | -87.0% |